Artesunate/mefloquine in Brazil, India, and Malaysia. In 2012 a course of treatment cost 2.50 USD. It is not commercially available in the United States. Artesunate/mefloquine is a recommended treatment in Southeast Asia while in Africa artesunate/amodiaquine, artemether/lumefantrine, artesunate/sulfadoxine/pyrimethamine are often preferred. Artesunate/mefloquine Artesunate/mefloquine is a medication used to treat malaria. It is a fixed dose combination of artesunate and mefloquine. Specifically it is recommended to treat uncomplicated falciparum malaria. It is taken by mouth. Side effects are similar to the medications being used separately. Use is recommended as it decreases the possibility of either medications being used alone. Dose forms appropriate
Alternative treatments used for the common cold children by 18%. Vitamin C also decreased the severity of colds. A systematic review by the Cochrane Collaboration, last updated in 2014, examines twenty-four randomized controlled trials studying various echinacea preparations for prevention and treatment of the common cold. Echinacea showed no benefit over placebo for prevention. Evidence for treatment was inconsistent. Reported side effects were rare. 2007 meta-analyses conclude that there is some evidence that echinacea may reduce either the duration or severity of the common cold, but results are not consistent. Use of echinacea preparations is not currently recommended. In the twelfth century, Moses Maimonides wrote, "Chicken soup